Internal Medicine, Hematology & Oncology · Miami, FL
NPI
1912995101
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1321 NW 14th St, Ste 305
Miami, FL, 33125
Phone (305) 545-4545
Groups this clinician bills Medicare through
Medicare paid, 2024
$381K
26,793 services
Medicare patients, 2024
115
Average age 75
Drug cost, 2024
$6.4M
2,740 prescriptions
Company payments, 2025
$4,925
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jolly Varki was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 1,728 times for 15 patients. In total Jolly Varki billed 26,793 services in 65 codes, and Medicare paid $381K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,728 | 15 | $0.07 | $128 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,079 | 15 | $0.09 | $97.25 |
| 96367 Intravenous Infusion, Hydration | Office | 442 | 23 | $22.92 | $10K |
| 85025 Blood Count | Office | 429 | 87 | $7.61 | $3,265 |
| 36415 Venipuncture Blood Collection | Office | 427 | 86 | $8.65 | $3,694 |
| 99214 Office E&M - Established | Office | 260 | 99 | $104.45 | $27K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 205 | 22 | $0.64 | $132 |
| 96415 Chemotherapy Administration | Office | 154 | 14 | $22.75 | $3,504 |
| 96413 Chemotherapy Administration | Office | 137 | 18 | $105.96 | $15K |
| 96365 Intravenous Infusion, Hydration | Office | 90 | 12 | $51.00 | $4,590 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 64 | 13 | $141.09 | $9,030 |
| 96402 Chemotherapy Administration | Office | 57 | 16 | $28.83 | $1,643 |
| 99204 Office E&M - New | Office | 19 | 19 | $141.57 | $2,690 |
By year: 2022 $617K for 44,522 services; 2023 $543K for 52,076 services; 2024 $381K for 26,793 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 429 | 87 | $7.61 | $3,265 |
| 36415 Venipuncture Blood Collection | 427 | 86 | $8.65 | $3,694 |
Medicare prescription drug claims, 2024
In 2024, the drug Jolly Varki prescribed most often to Medicare patients was Letrozole, with 226 prescriptions and refills. In total Jolly Varki wrote 2,740 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 226 | 611 | 65 | $4,624 |
| Bicalutamide Generic | 188 | 461 | 57 | $7,547 |
| Diphenhydramine Hcl Generic | 169 | 169 | 28 | $665 |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 167 | 173 | 25 | $2,393 |
| Ondansetron Hcl Generic | 127 | 127 | 40 | $1,423 |
| Anastrozole Generic | 104 | 280 | 35 | $1,327 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 93 | 99 | 15 | $283 |
| Xtandi Enzalutamide | 82 | 82 | Under 11 | $1.2M |
| Fluorouracil Generic | 64 | 64 | Under 11 | $3,174 |
| Imatinib Mesylate Generic | 60 | 64 | Under 11 | $34K |
| Darzalex Daratumumab | 58 | 58 | Under 11 | $471K |
| Eliquis Apixaban | 53 | 74 | Under 11 | $43K |
| Acyclovir Generic | 53 | 113 | 15 | $359 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 72 | 11 | $192 |
| Trelstar Triptorelin Pamoate | 45 | 135 | 14 | $117K |
Brand drugs: 684 claims; generic drugs: 2,056 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jolly Varki $4,925 ($4,925 in general payments such as food, travel and fees) from 33 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $897.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 33 | $897 |
| Pfizer Inc. PFE | 23 | $587 |
| Janssen Biotech, Inc. JNJ | 21 | $512 |
| Daiichi Sankyo Inc. 4568.T | 9 | $347 |
| Celgene Corporation BMY | 10 | $293 |
| Merck Sharp & Dohme LLC MRK | 12 | $278 |
| Astellas Pharma US Inc 4503.T | 6 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $182 |
| Boston Scientific Corporation BSX | 1 | $169 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.